Virtus Investment Advisers’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $92K | Sell |
6,894
-2,013
| -23% | -$26.9K | 0.03% | 367 |
|
|
2025
Q1 | $90.8K | Buy |
+8,907
| New | +$90.8K | 0.02% | 433 |
|
|
2023
Q3 | – | Sell |
-2,953
| Closed | -$119K | – | 272 |
|
|
2023
Q2 | $119K | Sell |
2,953
-5,422
| -65% | -$218K | 0.08% | 235 |
|
|
2023
Q1 | $358K | Buy |
8,375
+262
| +3% | +$11.2K | 0.25% | 120 |
|
|
2022
Q4 | $390K | Hold |
8,113
| – | – | 0.26% | 121 |
|
|
2022
Q3 | $305K | Buy |
+8,113
| New | +$305K | 0.14% | 143 |
|